The loss of ZG16 associated with CRC development has led to the hypothesis that ZG16 reduction may disrupt well-organized bacterial surveillance systems to facilitate bacterial invasion of host tissues and cause local inflammatory changes, which may constitute an increased risk for the development of cancer [78]. The gene discussed is ZG16; the disease is colorectal carcinoma.